Rolling coverage of the latest economic and financial news Pharmaceuticals news: AstraZeneca is investing $2bn in biopharmaceutical oncology company Summit Therapeutics, as part of a tie-up to jointly develop and test anti-cancer drugs.
Back to Business
Business
September 29, 2026 at 6:48 AM
Anthropic warns of ‘existential risks to humanity’ from AI; AstraZeneca makes $2bn cancer drug tie-up – business live
The Guardian Business
Excerpt from The Guardian Business.